Revolutionizing Heart Health: How SCAPIS Aims to Prevent Heart Attacks
Every year, approximately 8,000 individuals under the age of 70 experience their first heart attack, with over 1,000 of these cases resulting in death. To combat this alarming trend, Dr. Göran Bergström, a chief physician at Sahlgrenska University Hospital in Gothenburg, has spearheaded a groundbreaking initiative aimed at reducing the incidence of heart attacks by 2030.
As the scientific leader of SCAPIS (Swedish CardioPulmonary bioImage Study), the world's largest study of its kind, Dr. Bergström’s efforts bring together six universities and university hospitals to investigate the heart, blood vessels, and lungs of 30,000 residents. This monumental research aims to predict and prevent heart and lung diseases, especially among those who are asymptomatic yet at risk.
Dr. Bergström emphasizes the importance of identifying healthy individuals who may unknowingly carry a high risk of a heart attack. "My goal is to discover tools that will highlight these individuals before it's too late," he says, underscoring the innovative nature of SCAPIS.
Among the participants in the study, researchers have detected significant changes within the blood vessels of more than 40% of the individuals examined. While most changes were minor, about one in twenty showcased alarming alterations, all while remaining unaware of their risk. Dr. Bergström notes that while this method of examination is resource-intensive, researchers are exploring advanced technologies such as a simple blood test that could efficiently pinpoint those at risk.
"If we're successful in identifying these individuals, we can offer preventive assistance to avert heart attacks," he explains. The solution primarily revolves around lifestyle adjustments and the availability of effective medications. Dr. Bergström is optimistic about discovering simple ways to identify high-risk individuals conveniently and cost-effectively, suggesting that blood measurements could become a practical screening tool.
The financial aspect of SCAPIS cannot be overstated. The Heart-Lung Foundation has taken on the role of primary financier, and according to Dr. Bergström, every donation plays a substantial role in progressing the research. Despite the ability to measure numerous blood indicators and variables, the funding is vital for researchers to capture the full spectrum of what they wish to study.
As Dr. Bergström passionately concludes, "We are on the cusp of potentially revolutionizing how we combat heart attack risks. If SCAPIS succeeds in developing an intelligent and affordable screening method, we could considerably reduce the number of individuals in the risk category by 20 to 30% by 2030."
In order to bring these groundbreaking plans to life and continue the research needed to save lives, contributions from the public are essential. Every little bit helps on the path to preventing heart attacks before they arise.
Related Sources: